Your session is about to expire
← Back to Search
In-Clinic Endoscopic Polypectomy for Nasal Polyps
Study Summary
This trial will compare the effectiveness of a new in-clinic sinus surgery procedure to the current standard operating room procedure.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with allergic fungal sinusitis.I have nasal polyps that are causing my nose to change shape.I've had surgery that affects the grading of nasal polyps.I have a condition that weakens my immune system.My health is good enough for surgery according to the ASA classification.You are allergic to or cannot use certain numbing medications or nasal sprays.I have moderate to severe nasal polyps in both nostrils.I often have a blocked nose, as per my recent test results.I cannot take oral corticosteroids due to health reasons.I have a history of Churg-Strauss syndrome, primary ciliary dyskinesia, or vasculitis.I am not fit for surgery under general anesthesia.I cannot have procedures done while awake.I have been diagnosed with AERD.I am 18 years old or older.I experience significant facial pain or pressure.I have chronic sinusitis with polyps and need surgery after trying other treatments.I understand the study's purpose and procedures and agree to participate.I have been diagnosed with cystic fibrosis.I am not pregnant or breastfeeding.I have major issues with the structure of my mouth, like an unrepaired cleft palate.I need surgery to correct a deviated septum for further nasal procedures.My asthma or COPD has been stable with no flare-ups in the last 3 months.
- Group 1: Endoscopic Sinus Surgery (ESS)
- Group 2: Endoscopic polypectomy in clinic (EPIC)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there still an opportunity to participate in this research?
"Affirmative. Online records from clinicaltrials.gov indicate that this medical trial is presently recruiting patients, with the initial posting occurring on April 11th 2017 and the last update taking place September 20th 2022. 140 subjects are needed across 4 separate clinics."
How many patients is the clinical trial recruiting for participation?
"Affirmative. According to the info available on clinicaltrials.gov, this research is currently looking for participants - with 140 individuals sought from 4 sites. The trial was originally posted in April 2017 and its most recent update occurred on September 20th 2022."
To what capacity is this experiment being implemented in various locations?
"Presently, this trial is being conducted at 4 distinct sites: Ottawa, London, Montréal and other nearby locales. To limit the amount of travel required for participants, it's best to select the closest location available."
Share this study with friends
Copy Link
Messenger